Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Infections

Explore clinical trials studying Central Nervous System Infections. Study availability and eligibility vary by location and protocol.

758 public trials 80 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Infections trial results

Active, not recruiting

PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717

NCT06153966

Conditions
Central Nervous System Diseases, Central Nervous System Infections, Infections, +4 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • NYU Langone Health New York, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
  • Royal Melbourne Hospital Parkville, Australia
View all 13 locations
View Trial Details
Active, not recruiting

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

NCT06947499

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations
  • Care CT Group Dasmariñas, Cavite, Philippines
View Trial Details
Active, not recruiting

A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults

NCT07226882

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Borrelia Infections, +12 more
Locations
  • IMA Clinical Research Warren Warren Township, New Jersey, United States
  • Smith Allergy and Asthma Specialists Cortland, New York, United States
  • Smith Allergy & Asthma Specialists Horseheads, New York, United States
  • Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, not recruiting

Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

NCT05087056

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Ventura, California, United States
  • GSK Investigational Site Macon, Georgia, United States
  • GSK Investigational Site Valparaiso, Indiana, United States
View Trial Details
Active, not recruiting

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

NCT06113198

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Incheon, South Korea
  • GSK Investigational Site Junggu, South Korea
  • GSK Investigational Site Kyungki-do, South Korea
  • GSK Investigational Site Seongnam-si Gyeonggi-do, South Korea
View Trial Details

Related conditions